Source:http://linkedlifedata.com/resource/pubmed/id/21839323
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2011-8-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1097-6787
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
654-6
|
pubmed:meshHeading |
pubmed-meshheading:21839323-Aged,
pubmed-meshheading:21839323-Amyloidosis,
pubmed-meshheading:21839323-Antineoplastic Agents,
pubmed-meshheading:21839323-Drug Eruptions,
pubmed-meshheading:21839323-Humans,
pubmed-meshheading:21839323-Male,
pubmed-meshheading:21839323-Purpura,
pubmed-meshheading:21839323-Thalidomide
|
pubmed:year |
2011
|
pubmed:articleTitle |
Lenalidomide-induced purpuric eruption: a new adverse cutaneous reaction.
|
pubmed:publicationType |
Letter,
Case Reports
|